Fanghong Li

2.4k total citations
90 papers, 1.8k citations indexed

About

Fanghong Li is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Fanghong Li has authored 90 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 26 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Fanghong Li's work include Adipokines, Inflammation, and Metabolic Diseases (13 papers), Cancer Research and Treatments (8 papers) and Nanoplatforms for cancer theranostics (6 papers). Fanghong Li is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (13 papers), Cancer Research and Treatments (8 papers) and Nanoplatforms for cancer theranostics (6 papers). Fanghong Li collaborates with scholars based in China, United States and Hong Kong. Fanghong Li's co-authors include Allan Z. Zhao, Xinyun Bi, Sujin Zhou, Jessica A. Gasser, David E. Kelley, Miriam Friedman‐Einat, Alexander J. Szalai, Alessandro Bisello, Steven Strom and Mark A. McCrory and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Fanghong Li

82 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanghong Li China 23 430 408 248 193 174 90 1.8k
Kai Su China 23 678 1.6× 201 0.5× 367 1.5× 281 1.5× 128 0.7× 71 1.9k
Yanyan Zhao China 35 1.1k 2.6× 402 1.0× 279 1.1× 96 0.5× 190 1.1× 171 3.1k
E Horváth Hungary 31 1.1k 2.6× 317 0.8× 496 2.0× 175 0.9× 208 1.2× 175 4.0k
Huihui Zhang China 23 1.1k 2.6× 628 1.5× 622 2.5× 136 0.7× 134 0.8× 67 2.7k
Huiqing Wang China 29 933 2.2× 334 0.8× 183 0.7× 62 0.3× 190 1.1× 154 2.4k
Suping Wang China 25 805 1.9× 202 0.5× 226 0.9× 100 0.5× 101 0.6× 78 2.3k
Zhongyi Chen China 23 1.1k 2.6× 204 0.5× 246 1.0× 103 0.5× 90 0.5× 62 2.4k
Magbubah Essack Saudi Arabia 29 1.4k 3.3× 280 0.7× 419 1.7× 186 1.0× 116 0.7× 81 2.9k

Countries citing papers authored by Fanghong Li

Since Specialization
Citations

This map shows the geographic impact of Fanghong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanghong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanghong Li more than expected).

Fields of papers citing papers by Fanghong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanghong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanghong Li. The network helps show where Fanghong Li may publish in the future.

Co-authorship network of co-authors of Fanghong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fanghong Li. A scholar is included among the top collaborators of Fanghong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanghong Li. Fanghong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Guifang, Fanghong Li, Le Wang, et al.. (2025). Saikosaponin D exacerbates acetaminophen-induced liver injury by sabotaging GABARAP-SNARE complex assembly in protective autophagy. Phytomedicine. 138. 156409–156409. 3 indexed citations
2.
Wang, Xinzi, et al.. (2024). 10-Hydroxy-2-decenoic acid attenuates nonalcoholic fatty liver disease by activating AMPK-α signaling pathway. Biochemical Pharmacology. 231. 116648–116648. 3 indexed citations
3.
Li, Fanghong, Qi Han, Yajie Cai, et al.. (2024). Si-Ni-San ameliorates cholestatic liver injury by favoring P. goldsteinii colonization. Journal of Ethnopharmacology. 337(Pt 1). 118804–118804. 4 indexed citations
4.
Li, Yufei, Zhi Ma, Guifang Fan, et al.. (2024). Rehmanniae Radix Praeparata aqueous extract improves hepatic ischemia/reperfusion injury by restoring intracellular iron homeostasis. Chinese Journal of Natural Medicines. 22(9). 769–784. 3 indexed citations
5.
Zhou, Sujin, Shiwei Zhang, Zixuan Li, et al.. (2024). Salmonella-mediated methionine deprivation drives immune activation and enhances immune checkpoint blockade therapy in melanoma. Journal for ImmunoTherapy of Cancer. 12(2). e008238–e008238. 13 indexed citations
6.
Cai, Yajie, et al.. (2024). Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway. EBioMedicine. 111. 105491–105491. 9 indexed citations
7.
Li, Yuyu, Xin He, Shiri Li, et al.. (2024). The phosphodiesterase-4 inhibitor Zl-n-91 suppresses glioblastoma growth via EGR1/PTEN/AKT pathway. European Journal of Pharmacology. 988. 177230–177230.
8.
9.
Zhou, Sujin, et al.. (2023). Endogenous production of ω-3 polyunsaturated fatty acids mitigates cisplatin-induced myelosuppression by regulating NRF2-MDM2-p53 signaling pathway. Free Radical Biology and Medicine. 201. 14–25. 11 indexed citations
10.
Zhou, Hongyu, et al.. (2023). Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease. Orphanet Journal of Rare Diseases. 18(1). 275–275. 6 indexed citations
11.
Wang, Shuai, et al.. (2023). Eicosapentaenoic acid metabolites promotes the trans-differentiation of pancreatic α cells to β cells. Biochemical Pharmacology. 216. 115775–115775. 4 indexed citations
12.
Zhou, Sujin, Shiwei Zhang, Tian Xue, et al.. (2023). Prognosis prediction based on methionine metabolism genes signature in gliomas. BMC Medical Genomics. 16(1). 317–317. 2 indexed citations
13.
Zhou, Sujin, Yan Lin, Mengmeng Lü, et al.. (2023). Targeted deprivation of methionine with engineered Salmonella leads to oncolysis and suppression of metastasis in broad types of animal tumor models. Cell Reports Medicine. 4(6). 101070–101070. 25 indexed citations
14.
Xu, Lin, Naïf Abdullah Al-Dhabi, Fanghong Li, et al.. (2023). Relative contribution of ammonia-oxidizing bacteria and denitrifying fungi to N2O production during rice straw composting with biochar and biogas residue amendments. Bioresource Technology. 390. 129891–129891. 17 indexed citations
15.
Zheng, Qi, Xiaojiaoyang Li, Nana Huang, et al.. (2022). Saikosaponins ameliorate hyperlipidemia in rats by enhancing hepatic lipid and cholesterol metabolism. Journal of Ethnopharmacology. 305. 116110–116110. 20 indexed citations
16.
17.
Lin, Xu, Nanyi Wang, Fanghong Li, et al.. (2022). Evaluation of the synergistic effects of biochar and biogas residue on CO2 and CH4 emission, functional genes, and enzyme activity during straw composting. Bioresource Technology. 360. 127608–127608. 58 indexed citations
18.
Zhou, Hongyu, Zhicheng Liang, Zhaoyang Li, et al.. (2022). Development of Lanzyme as the Potential Enzyme Replacement Therapy Drug for Fabry Disease. Biomolecules. 13(1). 53–53. 2 indexed citations
19.
Bai, Xiaoming, Jiaofang Shao, Sujin Zhou, et al.. (2019). Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 479–479. 57 indexed citations
20.
Chen, Ke, Fanghong Li, Ji Li, et al.. (2006). Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nature Medicine. 12(4). 425–432. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Su Breakdown of academic impact, for papers by Yanyan Zhao Breakdown of academic impact, for papers by E Horváth Breakdown of academic impact, for papers by Huihui Zhang Breakdown of academic impact, for papers by Huiqing Wang Breakdown of academic impact, for papers by Suping Wang Breakdown of academic impact, for papers by Zhongyi Chen Breakdown of academic impact, for papers by Magbubah Essack
Rankless by CCL
2026